In Vivo Fibrinolytic Activity and Pharmacology of Various Plasmin (Fibrinolysin) Preparations
- 1 July 1956
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 4 (4), 440-443
- https://doi.org/10.1161/01.res.4.4.440
Abstract
A quantitative method based on the disappearance of I131 labeled fibrin has been used to study the in vivo effect of fibrinolytic agents. Various preparations of human and bovine plasmin were found to lyse clots effectively. The minimal effective dose of human plasmin prepared by the method of Kline was 15 Loomis units/Kg. Plasmin preparations given intravenously produced hypotension and leukopenia followed by leukocytosis. Doses above 30 Loomis units/Kg. caused decrease in fibrinogen level and clotting index.Keywords
This publication has 6 references indexed in Scilit:
- Quantitative Method for the In Vivo Testing of Fibrinolytic Agents: Effect of Intravenous Trypsin on Radioactive Thrombi and EmboliCirculation Research, 1956
- The Enzymatic Dissolution Of Experimental Arterial Thrombi in the Dog by Trypsin, Chymotrypsin and Plasminogen Activators12JCI Insight, 1954
- STUDIES ON THE PURIFICATION AND ACTIVATION OF PLASMINOGEN (PROFIBRINOLYSIN)1954
- In Vivo Studies of Human Plasmin. Intravenous Injection in Dogs and RabbitsJournal of Applied Physiology, 1953
- PHYSIOLOGICAL EFFECTS OF A PLASMA PROTEIN: BLOOD PRESSURE, LEUCOCYTE CONCENTRATION, SMOOTH AND CARDIAC MUSCLE ACTIVITYAmerican Journal of Physiology-Legacy Content, 1947
- FIBRINOLYSIN - NOMENCLATURE, UNIT, ASSAY, PREPARATION AND PROPERTIES1947